Synendos Therapeutics AG announces that co-founder and Scientific Advisor Board member, Professor Jürg Gertsch, presented groundbreaking new findings on an endocannabinoid transporter at the 10th Gordon Research Conference - Monday the 17th 2023 at 07h00 PM.
Prof. Jürg Gertsch, provided for the first time new insights into the novel transport mechanism that influences the balance of the endocannabinoid system, identifying and characterising the biological machinery responsible for endocannabinoid cell reuptake.
Synendos investigates the therapeutic potential of this novel mode of action and Prof. Gertsch's pioneering research forms the basis of Synendos’ approach.
Read more details in the article:
